Spectral Medical Inc. (OTCMKTS:EDTXF) Short Interest Down 5.2% in October

Spectral Medical Inc. (OTCMKTS:EDTXF) saw a significant drop in short interest in October. As of October 15th, there was short interest totalling 94,800 shares, a drop of 5.2% from the September 30th total of 100,000 shares. Based on an average daily trading volume, of 14,500 shares, the short-interest ratio is presently 6.5 days.

Spectral Medical Stock Performance

Shares of Spectral Medical stock remained flat at $0.41 during trading on Thursday. The business’s 50-day moving average is $0.46 and its two-hundred day moving average is $0.40. The stock has a market cap of $115.88 million, a PE ratio of -8.27 and a beta of 0.93. Spectral Medical has a 1 year low of $0.23 and a 1 year high of $0.55.

Spectral Medical (OTCMKTS:EDTXF) last released its earnings results on Friday, August 9th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.34 million during the quarter.

About Spectral Medical

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.